Gainers
- 4D Molecular Therapeutics FDMT shares moved upwards by 24.5% to $9.59 during Thursday's regular session. Trading volume for this security as of 13:30 EST is 994.4K, which is 361.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $310.5 million.
- Acorda Therapeutics ACOR stock increased by 23.78% to $0.6. As of 13:30 EST, Acorda Therapeutics's stock is trading at a volume of 12.0 million, which is 424.8% of its average full-day volume over the last 100 days. The company's market cap stands at $14.6 million.
- Community Health Systems CYH shares rose 21.7% to $2.8. Community Health Systems's stock is trading at a volume of 5.5 million shares as of 13:30 EST. This is 184.7% of its average full-day volume over the last 100 days. The company's market cap stands at $377.0 million. The company's, Q3 earnings came out yesterday.
- Surface Oncology SURF stock increased by 15.92% to $1.31. Trading volume for this security as of 13:30 EST is 880.3K, which is 181.1% of its average full-day volume over the last 100 days. The company's market cap stands at $76.0 million.
- NeuroBo Pharmaceuticals NRBO stock rose 12.82% to $9.15. As of 13:30 EST, NeuroBo Pharmaceuticals's stock is trading at a volume of 2.1 million, which is 399.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.1 million.
- Eton Pharmaceuticals ETON shares rose 12.78% to $2.65. Eton Pharmaceuticals's stock is trading at a volume of 181.6K shares as of 13:30 EST. This is 263.7% of its average full-day volume over the last 100 days. The company's market cap stands at $67.0 million.
Losers
- TransCode Therapeutics RNAZ shares declined by 20.9% to $0.91 during Thursday's regular session. The current volume of 1.9 million shares is 367.8% of TransCode Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $11.8 million.
- Taysha Gene Therapies TSHA shares decreased by 19.45% to $1.74. The current volume of 10.9 million shares is 665.8% of Taysha Gene Therapies's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $71.5 million.
- Y-mAbs Therapeutics YMAB stock decreased by 19.03% to $8.91. Trading volume for this security as of 13:30 EST is 1.1 million, which is 387.6% of its average full-day volume over the last 100 days. The company's market cap stands at $389.7 million.
- Align Tech ALGN shares decreased by 17.51% to $182.84. Trading volume for Align Tech's stock is 2.3 million as of 13:30 EST. This is 273.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $14.2 billion. As per the press release, Q3 earnings came out yesterday.
- Tricida TCDA shares declined by 16.3% to $0.39. Trading volume for Tricida's stock is 17.5 million as of 13:30 EST. This is 526.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $21.7 million.
- ENDRA Life Sciences NDRA stock fell 14.28% to $0.27. As of 13:30 EST, ENDRA Life Sciences's stock is trading at a volume of 658.7K, which is 204.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in